Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing 2024-10-18 18:00
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow 2024-10-18 17:00
Ping An Health Upgrades Chronic Disease Management Services with Significant Results in Digital Weight Management Program 2024-10-18 12:13
Exclusive Interview with Lang Guojun, founder of Sanyou Bio: The Key to Breaking the Bottleneck of New Drug Innovation--The Past and Future of the Super-Trillion Molecule Library 2024-10-17 22:00
Chipscreen Biosciences' Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted 2024-10-17 21:38
Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress 2024-10-17 18:39
KIND Announces Late-Breaking Abstract Accepted for Presentation on AND017 Clinical Trials to Treat Anemia in Chronic Kidney Disease (CKD) at ASN - Kidney Week 2024 2024-10-17 15:44
EmeTerm Smart and HeadaTerm 2 Achieve Health Canada MDL Certification 2024-10-16 21:30
Copper-67 SAR-bisPSMA updates 2024-10-16 21:03
IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer 2024-10-16 19:02
TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections 2024-10-16 18:00
Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies 2024-10-16 17:43
SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA 2024-10-16 14:00
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting 2024-10-15 22:08
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation 2024-10-15 21:00
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration 2024-10-15 09:51
Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer 2024-10-14 21:02
Tsingke Shines at Cell & Gene Therapy International 2024 2024-10-14 20:11
1 4 5 6 7 8 430